BIOMAT Database Logo BIOMAT Database Logo

Mucoadhesive controlled-release formulations containing morin for the control of oral biofilms. 2022

Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Department of Morphology, Pediatric Dentistry and Orthodontics, School of Dentistry, São Paulo State University - UNESP, Araraquara, SP, Brazil.

This study aimed to evaluate the antimicrobial and anti-biofilm activity of morin on polymicrobial biofilms and its cytotoxicity in controlled-release films and tablets based on gellan gum. Polymicrobial biofilms were formed from saliva for 48 h under an intermittent exposure regime to 1% sucrose and in contact with films or tablets of gellan gum containing 2 mg of morin each. Acidogenicity, bacterial viability, dry weight and insoluble extracellular polysaccharides from biofilms were evaluated. The cytotoxicity of morin was evaluated in oral keratinocytes. Morin released from the systems reduced the viability of all the microbial groups evaluated, as well as the dry weight and insoluble polysaccharide concentration in the matrix and promoted the control of acidogenicity when compared with the control group without the substance. Morin was cytotoxic only at the highest concentration evaluated. In conclusion, morin is an effective agent and shows antimicrobial and anti-biofilm activity against polymicrobial biofilms.

UI MeSH Term Description Entries
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013295 Streptococcus mutans A polysaccharide-producing species of STREPTOCOCCUS isolated from human dental plaque.
D013607 Tablets Solid dosage forms, of varying weight, size, and shape, which may be molded or compressed, and which contain a medicinal substance in pure or diluted form. (Dorland, 28th ed) Tablet
D018441 Biofilms Encrustations formed from microbes (bacteria, algae, fungi, plankton, or protozoa) embedded in an EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX that is secreted by the microbes. They occur on body surfaces such as teeth (DENTAL DEPOSITS); inanimate objects, and bodies of water. Biofilms are prevented from forming by treating surfaces with DENTIFRICES; DISINFECTANTS; ANTI-INFECTIVE AGENTS; and anti-fouling agents. Biofilm

Related Publications

Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Mucoadhesive Formulation Designs for Oral Controlled Drug Release at the Colon.
January 2021, Current pharmaceutical design,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Mucoadhesive gels designed for the controlled release of chlorhexidine in the oral cavity.
September 2011, Pharmaceutics,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Mucoadhesive tablets for controlled release of acyclovir.
January 2012, Chemical & pharmaceutical bulletin,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Design and evaluation in vitro of controlled release mucoadhesive tablets containing chlorhexidine.
January 2006, Drug development and industrial pharmacy,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Design and study of rifampicin oral controlled release formulations.
January 2004, Drug delivery,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Soft robot-enabled controlled release of oral drug formulations.
February 2023, Soft matter,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
[Mucoadhesive oral tablets--a modern dosage form with controlled drug release].
March 2000, Ceska a Slovenska farmacie : casopis Ceske farmaceuticke spolecnosti a Slovenske farmaceuticke spolecnosti,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Surface-modified mucoadhesive microparticles as a controlled release system for oral delivery of insulin.
September 2019, Heliyon,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Novel mucoadhesive oral patch containing diazepam.
August 2005, Drug development and industrial pharmacy,
Aline Leite de Farias, and Maria Isabel Amaya Arbeláez, and Andréia Bagliotti Meneguin, and Hernane da Silva Barud, and Fernanda Lourenção Brighenti
Dry elixir formulations of dexibuprofen for controlled release and enhanced oral bioavailability.
February 2011, International journal of pharmaceutics,
Copied contents to your clipboard!